FLS vs GILD · P/E 25, $7.01B cap vs P/E 18, rev $7.80B
Flowserve Corporation (FLS) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Flowserve Corporation (FLS) is a specialty industrial machinery company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FLS revenue for 2026-06-30 was $0. Net income was $180.7M. FLS currently screens at market cap $7.01B and trailing P/E 25.1.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FLS currently screens at market cap $7.01B and trailing P/E 25.1. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FLS and GILD stock pages for the full models.
Not investment advice.